Hims Hers Health IncHIMS
▲ PositiveCapitalrelevance
Raises full-year revenue guidance despite wider loss, indicating stronger expected demand.
Impact on stocks 1
Health Care
Hims Hers Health IncHims & Hers Health raised its full-year revenue outlook even as it swung to a net loss in the second quarter. Revenue rose 38% year over year to $753.2 million, subscribers increased 19% to 2.89 million, and the company lifted its full-year revenue forecast to $3.1 billion to $3.3 billion from $2.8 billion to $3.0 billion. However, the company reported an $86.3 million net loss, or 37 cents per share, compared with a $42.5 million profit a year earlier, while gross margin fell to 64% from 76%. Adjusted EBITDA declined 27% to $60.3 million, and the company narrowed its full-year adjusted EBITDA guidance to $275 million to $325 million from $275 million to $350 million.
Hims Hers Health IncRaises full-year revenue guidance despite wider loss, indicating stronger expected demand.